Sciarra Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SCIARRA LABS, and what generic and branded alternatives to SCIARRA LABS drugs are available?
SCIARRA LABS has two approved drugs.
Summary for Sciarra Labs
| US Patents: | 0 |
| Tradenames: | 2 |
| Ingredients: | 1 |
| NDAs: | 2 |
Drugs and US Patents for Sciarra Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sciarra Labs | SCLEROSOL | talc | AEROSOL;INTRAPLEURAL | 020587-001 | Dec 24, 1997 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| Sciarra Labs | TALC | talc | POWDER;INTRAPLEURAL | 021388-001 | Dec 15, 2003 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
